| 2026-08-06 | Press release | Q2 2026 Financial Results |
| 2026-07-28 | Press release | Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer |
| 2026-07-16 | Press release | Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 |
| 2026-06-29 | Press release | Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes |
| 2026-06-11 | Press release | Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program |
| 2026-05-28 | Press release | Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference |
| 2026-05-28 | Press release | Download PDF file_download |
| 2026-05-12 | Press release | Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update |
| 2026-05-12 | Presentation | Unlocking Life Changing Therapies |
| 2026-05-12 | Press release | Download PDF file_download |
| 2026-05-06 | Press release | Download PDF file_download |
| 2026-05-05 | Press release | Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026 |
| 2026-05-05 | Press release | Download PDF file_download |
| 2026-03-19 | Press release | Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update |
| 2026-03-09 | Press release | Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer |
| 2026-03-09 | Press release | Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing |
| 2026-01-12 | Press release | Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for |
| 2025-03-27 | Press release | Relmada Therapeutics Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update |
| 2025-03-26 | Press release | Relmada Therapeutics to Report Fourth Quarter 2024 Financial Results on Thursday, March 27, 2025 |
| 2024-11-07 | Press release | Relmada Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update |
| 2024-11-04 | Press release | Relmada Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024 |
| 2024-08-05 | Press release | Relmada Therapeutics to Report Second Quarter 2024 Financial Results on August 7, 2024 |
| 2024-06-30 | Press release | Relmada Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update |
| 2024-05-08 | Press release | Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results |
| 2024-03-19 | Press release | Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results |
| 2023-11-08 | Press release | Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results |
| 2023-08-08 | Press release | Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results |
| 2023-05-11 | Press release | Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results |
| 2023-03-23 | Press release | Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results |
| 2022-11-10 | Press release | Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results |
| 2022-08-11 | Press release | Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results |
| 2022-05-05 | Press release | Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results |
| 2022-03-23 | Press release | Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results |
| 2021-11-11 | Press release | Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results |
| 2021-08-10 | Press release | Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results |
| 2021-05-01 | Press release | Relmada Therapeutics Announces Poster Presentations at the American Psychiatric Association Annual Meeting 2021 |